Why does leakage of drugs from poor to rich markets matter?
Because a firm might be quite glad to gain new revenue from the “poor” market, however small, or even to do good, but it is bound to resist approaches which mean it loses the chance to make as much money as possible from rich markets. In short: a firm might not mind very low profits in some markets, but overall – there have to be profits.
